Skip to main content
SINSIN PHARMACEUTICAL Co., LTD. logo

SINSIN PHARMACEUTICAL Co., LTD. — Investor Relations & Filings

Ticker · 002800 ISIN · KR7002800001 KO Manufacturing
Open in API
Filings indexed 175 across all filing types
Latest filing 2019-03-05 Proxy Solicitation & In…
Country KR South Korea
Listing KO 002800

About SINSIN PHARMACEUTICAL Co., LTD.

https://sinsin2002.tradekorea.com/

Sinsin Pharmaceutical Co., Ltd. is a pharmaceutical company that specializes in the development, manufacturing, and marketing of over-the-counter (OTC) medicines for external use. The company's core product portfolio centers on topical anti-inflammatory and analgesic drugs, including its widely recognized brand of pain relief patches, "SINSIN PAS," alongside various sprays and lotions. The company also produces a diverse range of consumer healthcare items such as mosquito repellents, wound care products like surgical plasters and healing bands, anti-mycotic treatments, and other dermatological preparations for both domestic and overseas markets.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Reference Document' (참고서류) for the 56th Annual General Meeting of Shinsin Pharmaceutical Co., Ltd. It contains detailed information regarding the solicitation of proxy voting, the agenda for the meeting, and the financial statements (balance sheet, income statement, etc.) for the fiscal year 2018. This type of document, which provides information to shareholders to request votes for an upcoming meeting, is classified as a Proxy Solicitation & Information Statement.
2019-03-05 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Shinshin Pharmaceutical. It outlines the date, location, and agenda items (such as financial statement approval, dividend declaration, and election of directors/auditors). This type of document is a standard proxy solicitation/information statement provided to shareholders to inform them of upcoming meeting details and voting items.
2019-02-20 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Shinshin Pharmaceutical regarding the decision to pay a cash dividend. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2019-02-20 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (Shinshin Pharmaceutical) announcing a significant change in revenue or profit structure (30% or more). This is a standard regulatory disclosure requirement in the Korean market (DART system) for material financial changes. Since it provides specific financial highlights and reasons for the change (e.g., increased advertising costs) rather than being a full annual report or a simple announcement of a report's availability, it falls under the 'Earnings Release' category as it serves as an initial announcement of financial performance metrics.
2019-02-07 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed under the Capital Markets Act in South Korea. This type of filing is specifically used to notify the market when an entity's shareholding in a listed company crosses certain thresholds (e.g., 5%). This falls under the 'Major Shareholding Notification' category.
2019-01-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea (often referred to as a 'Section 16' equivalent in the US) to report changes in shareholdings by company insiders. Based on the provided filing categories, this falls under 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2019-01-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.